Video

The Significance of Allergic Reactions to Vaccines

Author(s):

John Kelso, MD, Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, explained the concerns researchers had of administering vaccines to patients experiencing allergic reactions to those vaccines.

John Kelso, MD, Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, outlined the main points from the talks he gave at the AAAAI 2017 meeting in Atlanta, Georgia. Kelso explained that the most important message, he felt, had to do with the relationship between the influenza vaccine and egg allergies. For quite some time, researchers had surmised that if a patient was allergic to eggs, he shouldn't receive an influenza vaccine, because the vaccine is grown in eggs and contains egg protein. Experts were concerned that if these patients were, in fact, administered the influenza vaccine, the patients would experience anaphylactic reactions.

However, during the last decade, researchers had conduced several studies in which they gave patients, with definitive egg allergies, the influenza vaccine, without seeing any adverse reactions. Based on these results, the American Academy of Pediatrics and the Advisory Committee on Immunization Practices from the US Centers for Disease Control and Prevention released new recommendations and guidance on administering the influenza vaccine. According to Kelso, the updated recommendation specifically said that egg allergies are not risk factors for having a reaction to influenza vaccines.

Kelso said that the unanswered question was whether it's okay for patients who experience allergic reactions to vaccines to get them in the first place - the alternative is the risk of leaving patients unvaccinated.

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Enhancing Standards for Ethical Responsibilities within Clinical Research
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
© 2025 MJH Life Sciences

All rights reserved.